142 related articles for article (PubMed ID: 32697010)
1. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
Candoni A; Farina F; Perruccio K; Di Blasi R; Criscuolo M; Cattaneo C; Delia M; Zannier ME; Dragonetti G; Fanci R; Martino B; Del Principe MI; Fianchi L; Vianelli N; Chierichini A; Garzia M; Petruzzellis G; Nadali G; Verga L; Busca A; Pagano L
Mycoses; 2020 Oct; 63(10):1094-1100. PubMed ID: 32697010
[TBL] [Abstract][Full Text] [Related]
2. 'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study.
Del Principe MI; Dragonetti G; Verga L; Candoni A; Marchesi F; Cattaneo C; Delia M; Potenza L; Farina F; Ballanti S; Decembrino N; Castagnola C; Nadali G; Fanci R; Orciulo E; Veggia B; Offidani M; Melillo L; Manetta S; Tumbarello M; Venditti A; Busca A; Aversa F; Pagano L;
J Antimicrob Chemother; 2019 Apr; 74(4):1062-1068. PubMed ID: 30649413
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
Filì C; Candoni A; Zannier ME; Olivieri J; Imbergamo S; Caizzi M; Nadali G; Di Bona E; Ermacora A; Gottardi M; Facchinelli D; Ciancia R; Lazzarotto D; Dubbini MV; Festini G; Gherlinzoni F; Michieli MG; Semenzato G; Fanin R
Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
[TBL] [Abstract][Full Text] [Related]
6. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal consecutive infections in a patient with acute myeloid leukaemia.
Safai Nodeh SR; Dehghan Manshadi SA; Jahanbin B; Khodaveisi S; Giasvand F; Seifi A; Salehi M
Niger J Clin Pract; 2019 Apr; 22(4):582-584. PubMed ID: 30975967
[TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.
Michallet M; Bénet T; Sobh M; Kraghel S; El Hamri M; Cannas G; Nicolini FE; Labussière H; Ducastelle S; Barraco F; Thomas X; Chelghoum Y; Nicolle MC; Bienvenu AL; Persat F; De Monbrison F; Picot S; Vanhems P
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):991-7. PubMed ID: 21909650
[TBL] [Abstract][Full Text] [Related]
10. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
Lazzarotto D; Candoni A; Nadali G; Pavan L; Lessi F; Mosna F; Simeone E; Ventura G; Gherlinzoni F; Semenzato G; Pizzolo G; Fanin R
Eur J Haematol; 2016 Jun; 96(6):586-92. PubMed ID: 26186084
[TBL] [Abstract][Full Text] [Related]
11. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
[TBL] [Abstract][Full Text] [Related]
12. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
13. The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy.
Chen Y; Yang T; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Hu J
Medicine (Baltimore); 2016 Jul; 95(30):e4182. PubMed ID: 27472687
[TBL] [Abstract][Full Text] [Related]
14. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of efficacy and prognosis of induction chemotherapy in 76 elderly patients with acute myeloid leukemia (non-APL)].
Yang H; Niu JH; Zhu CY; Zhang Q; Zhu HY; Yao ZL; Zhou MH; Wang QS; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):957-64. PubMed ID: 25130810
[TBL] [Abstract][Full Text] [Related]
16. Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.
Girmenia C; Micozzi A; Piciocchi A; Gentile G; Di Caprio L; Nasso D; Minotti C; Capria S; Cartoni C; Alimena G; Meloni G; Amadori S; Foà R; Venditti A
Leuk Res; 2014 Apr; 38(4):469-74. PubMed ID: 24534569
[TBL] [Abstract][Full Text] [Related]
17. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute leukemia complicated by invasive aspergillosis in children].
Liu Y; Tang SQ; Wang JW; Long H; Feng C; Zhang H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):901-4. PubMed ID: 20113657
[TBL] [Abstract][Full Text] [Related]
19. Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome.
van de Peppel RJ; Dekkers OM; von dem Borne PA; de Boer MG
Med Mycol; 2014 Oct; 52(7):699-705. PubMed ID: 25049037
[TBL] [Abstract][Full Text] [Related]
20. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
